Objective: Biofilm formation significantly impacts infection risks in peritoneal dialysis (PD) patients. However, few studies focused on biofilms on PD catheters. This study aims to explore the formation and characteristics of bacterial biofilm on PD catheters.
Methods: A retrospective study was conducted on maintenance PD patients from January 2007 to January 2024. We summarized the general characteristics of the patients, the reasons for catheter removal, scanning electron microscopy (SEM) results of the PD catheter, and bacterial culture results from the PD effluent. The selected patients were divided into two groups: catheter removal due to peritonitis group (20 cases) and catheter removal due to non-peritonitis group (8 cases).
Results: (1) The average dialysis duration in catheter removal due to peritonitis group was 84.2โยฑโ46.6 months, significantly longer than that in catheter removal due to non-peritonitis group (21.8โยฑโ18.7 months). Thirteen patients (65.5%) in catheter removal due to peritonitis group had a history of peritonitis before the current episode, whereas none in catheter removal due to non-peritonitis group had experienced it previously (pโ=โ0.002). (2) Bacterial biofilm was detected in 20 (71.4%) out of 28 patients. Of these, bacterial biofilm was found in 18 patients (90.0%) in catheter removal due to peritonitis group, compared to only 2 patients (25.0%) in catheter removal due to non-peritonitis group (pโ=โ0.002). SEM revealed that the bacterial biofilm forms present on the PD catheters were exclusively cocci biofilms. The bacterial culture results from the PD fluid of patients in catheter removal due to peritonitis group indicated that the three most prevalent pathogens were Escherichia coli (7/20), methicillin-sensitive Staphylococcus aureus (3/20), and Staphylococcus epidermidis (3/20).
Conclusion: Bacterial biofilm formation on PD catheters is common among long-term PD patients. It is important to note that not all PD catheters removed due to peritonitis exhibit bacterial biofilms, and such biofilms may also be present in patients without peritonitis.
CostertonJWStewartPSGreenbergEP. Bacterial biofilms: a common cause of persistent infections. Science1999; 284: 1318โ1322.
5.
KusabaTKiritaYIshidaR, et al.Morphological analysis of biofilm of peritoneal dialysis catheter in refractory peritonitis patient. CEN Case Rep2012; 1: 50โ54.
6.
SwartzRMessanaJHolmesC, et al.Biofilm formation on peritoneal catheters does not require the presence of infection. ASAIO Trans1991; 37: 626โ634.
LiPKChowKMChoY, et al.ISPD Peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int2022; 42: 110โ153.
9.
GormanSPAdairCGMawhinneyWM. Incidence and nature of peritoneal catheter biofilm determined by electron and confocal laser scanning microscopy. Epidemiol Infect1994; 112: 551โ559.
10.
PihlMDaviesJRJohanssonAC, et al.Bacteria on catheters in patients undergoing peritoneal dialysis. Perit Dial Int2013; 33: 51โ59.
11.
Da Cunha MdeLCaramoriJCFioravanteAM, et al.Significance of slime as virulence factor in coagulase-negative staphylococcus peritonitis in CAPD. Perit Dial Int2004; 24: 191โ193.
12.
GirardLPCeriHGibbAP, et al.MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis. Perit Dial Int2010; 30: 652โ656.
13.
ColombariBAlfanoGGamberiniC, et al.EDTA and taurolidine affect Pseudomonas aeruginosa virulence in vitro-impairment of secretory profile and biofilm production onto peritoneal dialysis catheters. Microbiol Spectr2021; 9: e0104721.
14.
KlimekKAreste FosalbaNRamirez LopezMA, et al.Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients. Nefrologia (Engl Ed)2020; 40: 197โ201.
15.
DemoulinNGoffinE. Intraperitoneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis. Perit Dial Int2009; 29: 548โ553.
16.
BoueryCAzeroualLHufnagelG, et al.Peritoneal dialysis catheter sterilization by urokinase administration in case of relapsing peritonitis: about four observations. Nephrol Ther2021; 17: 128โ131.
17.
TobudicSHarrisonNForstnerC, et al.Effect of peritoneal dialysis fluids on activity of echinocandins against Candida spp. biofilm. Med Mycol2017; 55: 790โ793.
18.
NodairaYIkedaNKobayashiK, et al.Risk factors and cause of removal of peritoneal dialysis catheter in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial2008; 24: 65โ68.
DanfordCJLinSCSmithMP, et al.Encapsulating peritoneal sclerosis. World J Gastroenterol2018; 24: 3101โ3111.
21.
KanjanabuchTLumlertgulNPearsonLJ, et al.Peritoneal dialysis-related peritonitis due to melioidosis: a potentially devastating condition. Perit Dial Int2017; 37: 183โ190.
22.
DasguptaMK. Biofilms and infection in dialysis patients. Semin Dial2002; 15: 338โ346.
23.
SampaioJMachadoDGomesAM, et al.Deciphering the contribution of biofilm to the pathogenesis of peritoneal dialysis infections: characterization and microbial behaviour on dialysis fluids. PLoS One2016; 11: e0157870.
